Skip to main content

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Red de investigación Renal

IP: Daniel Serón Micas
Collaborators: Joan López Hellin, Red de investigación Renal, Francesc Moreso Mateos, Enric Trilla Herrera, Natalia Ramos Terrades, Joana Sellarés Roig, Maria Teresa Salcedo Allende, Concepció Jacobs Cachá, Manel Perelló Carrascosa
Funding agency: Instituto de Salud Carlos III
Funding: 92250
Reference: RD12/0021/0013
Duration: 01/01/2013 - 31/12/2016

Kidney and sex hormones: Novel insights into development and progression of the metabolic syndrome

IP: Kidney and sex hormones: Novel insights into development and progression of the metabolic syndrome
Collaborators: Joan López Hellin, Concepció Jacobs Cachá, Andrea Caballero Garralda
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 266200
Reference: SAF2011-29506
Duration: 01/01/2012 - 31/12/2014

Ministerio de Ciencia

Acción andrógénica y función renal: Implicación de la Kidney androgen-regulated protein (KAP)

IP: Acción andrógénica y función renal: Implicación de la Kidney androgen-regulated protein (KAP)
Collaborators: Joan López Hellin, Maria Teresa Salcedo Allende, Concepció Jacobs Cachá
Funding agency: Sociedad Española de Nefrología (S.E.N.)
Funding: 18000
Reference: SENEFRO/01/08
Duration: 01/02/2009 - 31/01/2011

Patologia Cel·lular

IP: Patologia Cel·lular
Collaborators: Joan López Hellin, Ramón Vilalta Casas, Alvaro Domingo Madrid Aris, Francesc Moreso Mateos, Enric Trilla Herrera, Daniel Serón Micas, Luis Enrique Lara Moctezuma, Concepció Jacobs Cachá, Carles Xavier Raventós Busquets
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2009 SGR 75
Duration: 01/01/2010 - 30/04/2014

Related news

On April 18 and 19, the Vall d’Hebron Research Institute (VHIR) will once again join the Science Festival 2026 with a diverse and participatory program focused on health, innovation, and citizen engagement in research.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

Related professionals

Figuera Segarra, Nuria

Figuera Segarra, Nuria

Multidisciplinary Nursing Research Group
Read more
Rosales Linaeres, Marta

Rosales Linaeres, Marta

Multidisciplinary Nursing Research Group
Read more
Liz  Madrid, Sandra

Liz Madrid, Sandra

Multidisciplinary Nursing Research Group
Read more
Esteve Valverde, Enrique

Esteve Valverde, Enrique

Postdoctoral researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.